Pharmsville Statistics

Total Valuation

Pharmsville has a market cap or net worth of KRW 28.52 billion. The enterprise value is -9.03 billion.

Market Cap	28.52B
Enterprise Value	-9.03B

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Pharmsville has 7.73 million shares outstanding. The number of shares has decreased by -1.32% in one year.

Current Share Class	7.73M
Shares Outstanding	7.73M
Shares Change (YoY)	-1.32%
Shares Change (QoQ)	-0.53%
Owned by Insiders (%)	62.87%
Owned by Institutions (%)	n/a
Float	2.87M

Valuation Ratios

The trailing PE ratio is 18.01.

PE Ratio	18.01
Forward PE	n/a
PS Ratio	1.71
PB Ratio	0.44
P/TBV Ratio	0.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.71
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	24.23

Financial Position

The company has a current ratio of 19.04, with a Debt / Equity ratio of 0.00.

Current Ratio	19.04
Quick Ratio	17.92
Debt / Equity	0.00
Debt / EBITDA	0.06
Debt / FCF	-0.06
Interest Coverage	-6.10

Financial Efficiency

Return on equity (ROE) is 2.46% and return on invested capital (ROIC) is -0.26%.

Return on Equity (ROE)	2.46%
Return on Assets (ROA)	-0.24%
Return on Invested Capital (ROIC)	-0.26%
Return on Capital Employed (ROCE)	-0.42%
Revenue Per Employee	506.82M
Profits Per Employee	47.97M
Employee Count	33
Asset Turnover	0.24
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.00% in the last 52 weeks. The beta is -0.03, so Pharmsville's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-45.00%
50-Day Moving Average	3,511.30
200-Day Moving Average	4,482.78
Relative Strength Index (RSI)	64.20
Average Volume (20 Days)	26,232

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmsville had revenue of KRW 16.72 billion and earned 1.58 billion in profits. Earnings per share was 204.84.

Revenue	16.72B
Gross Profit	10.50B
Operating Income	-269.85M
Pretax Income	1.83B
Net Income	1.58B
EBITDA	405.04M
EBIT	-269.85M
Earnings Per Share (EPS)	204.84

Full Income Statement

Balance Sheet

The company has 37.68 billion in cash and 23.60 million in debt, giving a net cash position of 37.65 billion or 4,872.12 per share.

Cash & Cash Equivalents	37.68B
Total Debt	23.60M
Net Cash	37.65B
Net Cash Per Share	4,872.12
Equity (Book Value)	64.62B
Book Value Per Share	8,348.98
Working Capital	39.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -346.56 million and capital expenditures -26.18 million, giving a free cash flow of -372.74 million.

Operating Cash Flow	-346.56M
Capital Expenditures	-26.18M
Free Cash Flow	-372.74M
FCF Per Share	-48.23

Full Cash Flow Statement

Margins

Gross margin is 62.79%, with operating and profit margins of -1.61% and 9.47%.

Gross Margin	62.79%
Operating Margin	-1.61%
Pretax Margin	10.94%
Profit Margin	9.47%
EBITDA Margin	2.42%
EBIT Margin	-1.61%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.80%.

Dividend Per Share	100.00
Dividend Yield	2.80%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	48.96%
Buyback Yield	1.32%
Shareholder Yield	4.12%
Earnings Yield	5.55%
FCF Yield	-1.31%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmsville has an Altman Z-Score of 13.02.

Altman Z-Score	13.02
Piotroski F-Score	n/a